uCoil NMR platform for robust and high-throughput analysis of in vitro metabolic flux on living cells
Project Number5R21CA212958-03
Contact PI/Project LeaderKESHARI, KAYVAN R
Awardee OrganizationSLOAN-KETTERING INST CAN RESEARCH
Description
Abstract Text
Project Summary/Abstract:
Changes in cancer metabolism have been labeled as a cancer hallmark and many recent reports have focused
on the interrogation of metabolism with oncogenic progression. Currently, methods though to assess
metabolism are lacking both in sensitivity and throughput. Moreover, measurements of metabolic flux, which
govern the flow through a metabolic pathway, are very difficult to acquire on mass limited samples. There
remains a critical need to develop an approach that is sensitive (requiring small cell numbers) and high-
throughput (assaying multiple cell samples in parallel in short time periods).
Methods have recently been developed to increase the signal of nuclear magnetic resonance (NMR)
spectroscopy utilizing hyperpolarized molecules. This can afford a dramatic increase in NMR sensitivity of
greater than 10,000-fold, but systems needed to take advantage of this for assaying in vitro cell cultures are
lacking. We and others have developed in cell NMR methods to assay living cells non-invasively but these
require on the order of 108-109 cells, well outside of novel cancer models, such as stem cells and organoids as
well as any kind of high-throughput in vitro assay.
The objective of this innovative analysis proposal is to develop a micro-coil (µCoil) NMR platform which would
marry the sensitivity of extremely small volume µCoils with the ability to rapidly introduce hyperpolarized
molecules and non-invasively monitor metabolic fluxes in less than 104 cells. This enhancement would have a
10,000-fold increased sensitivity over traditional NMR approaches and nearly 1000-fold over destructive
LC/MS methods. In Aim 1, we will develop a single-well µCoil approach, which can measure metabolic flux on
104 cells and optimize homogeneity with validation as compared to immortal cancer cell lines. In Aim 2, we will
convert this single well system in a multi-well and multi-µCoil detection scheme, parallelizing the measurement.
It is the overarching goal of this proposal to develop a robust benchtop platform, which will transform the
approach to metabolic flux analysis in living cells. Utilizing a “lab on a chip” type approach this platform will be
low cost and thus readily able to be disseminated to change the way we characterize cancer biology.
Public Health Relevance Statement
Project Narrative:
Cancer metabolism has become an area of great interest, but tools to study cancer metabolism are lacking.
The goal of this proposed research is to develop a platform, which will change the way we assess cancer
metabolism in living cells by combining hyperpolarized molecules and a novel micro-coil NMR platform. We
aim to develop this approach, validate it in cancer cell lines and then engineer a parallelized version of the
platform capable of high-throughput analysis of samples.
No Sub Projects information available for 5R21CA212958-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R21CA212958-03
Patents
No Patents information available for 5R21CA212958-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R21CA212958-03
Clinical Studies
No Clinical Studies information available for 5R21CA212958-03
News and More
Related News Releases
No news release information available for 5R21CA212958-03
History
No Historical information available for 5R21CA212958-03
Similar Projects
No Similar Projects information available for 5R21CA212958-03